Skip to content

Effect of nebulization with Dexmedetomidine on heart rate and blood pressure during intubation

Efficacy of preoperative dexmedetomidine nebulization on blunting the hemodynamic response to laryngoscopy and intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048528
Enrollment
60
Registered
2022-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nebulized Dexmedetomidine: Nebulization with Dexmedetomidine at a dose of 1 μg/kg (mixed with normal saline to a total volume of 5 ml) given 30 minutes before induction of general anes

Sponsors

Dheeraj Gopal Ravindran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I or II fit patients. 2. Patients aged between 18 and 60 years of age. 3. Patients undergoing surgeries under general anaesthesia. 4. Haemodynamically stable patients with all routine investigations within normal limits and without any comorbidities. 5. Written informed consent from the concerned patient.

Exclusion criteria

Exclusion criteria: 1. Patients who are not willing to participate in the study. 2. Patients with ASA grade III and above physical status. 3. Patients who are aged less than 18 and more than 60 years of age. 4. Patients who are posted for emergency procedures. 5. Patients with known allergy to the study drugs. 6. Patients with difficult intubation. 7. Patients who are obese. 8. Patients who have psychiatric, neurological, neuromuscular or cardiovascular disease or impairment of hepatic or renal function.

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of preoperative dexmedetomidine nebulisation in blunting the stress response to laryngoscopy and intubation.Timepoint: During intubation till 10 minutes after intubation

Secondary

MeasureTime frame
To study any adverse effects from preoperative dexmedetomidine nebulisation.Timepoint: Any time during and after nebulization of dexmedetomidine

Countries

India

Contacts

Public ContactDheeraj Gopal Ravindran

Dr. D. Y. Patil Medical College, Hospital & Research Centre

chhayasuryawanshi@gmail.com9922888201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026